Home/Filings/4/0001415889-23-002189
4//SEC Filing

SINNOTT ROBERT A 4

Accession 0001415889-23-002189

CIK 0000896264other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 9:52 PM ET

Size

15.8 KB

Accession

0001415889-23-002189

Insider Transaction Report

Form 4
Period: 2023-02-06
SINNOTT ROBERT A
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-07+1,4565,816 total
  • Exercise/Conversion

    Common Stock

    2023-02-08+1,5446,706 total
  • Award

    Restricted Stock Units

    2023-02-06+9,22221,704 total
    Common Stock (9,222 underlying)
  • Tax Payment

    Common Stock

    2023-02-07$59.76/sh654$39,0835,162 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-071,45620,248 total
    Common Stock (1,456 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-081,54418,704 total
    Common Stock (1,544 underlying)
  • Tax Payment

    Common Stock

    2023-02-08$61.53/sh693$42,6406,013 total
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
  • [F2]On February 6th, 2022, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter.
  • [F3]Restricted Stock Units vest 25% on the anniversary of February 7th, 2022.
  • [F4]Restricted Stock Units vest 25% on the anniversary of February 8th, 2021.

Issuer

USANA HEALTH SCIENCES INC

CIK 0000896264

Entity typeother

Related Parties

1
  • filerCIK 0001298819

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 9:52 PM ET
Size
15.8 KB